|
|
||||||||
B Complexes 1
Department of Biological Sciences, Columbia University, New York, NY 10027
Mice deficient in the RelA (p65) subunit of NF-
B die during embryonic development. Fetal liver (FL) hemopoietic precursors from these mice were used to generate RelA-deficient lymphocytes by adoptive transfer into lethally irradiated mature lymphocyte-deficient recombination-activating gene-1-/- mice. Strikingly, RelA-/- lymphocyte generation was greatly diminished compared with that of RelA+/+ lymphocytes. The most dramatic reduction was noticed in the numbers of developing B cells, which were considerably increased when RelA-/- FL cells that were also TNFR1 deficient were used. The role of RelA was further investigated in FL-derived developing B cells in vitro. Our results show that RelA is a major component of constitutive and TNF-
-induced
B site-binding activity in developing B cells, and provide evidence for a direct role of TNF-
in killing RelA-/- B cells. The absence of RelA significantly reduced mRNA expression of the antiapoptotic genes cellular FLICE-inhibitory protein and Bcl-2. Retroviral transduction of RelA-/- B cells with either cFLIP or Bcl-2 significantly reduced TNF-
killing. Together, these results indicate that RelA plays a crucial role in regulating developing B cell survival by inhibiting TNF-
cytotoxicity.
This article has been cited by other articles:
![]() |
S. Vaira, T. Johnson, A. C. Hirbe, M. Alhawagri, I. Anwisye, B. Sammut, J. O'Neal, W. Zou, K. N. Weilbaecher, R. Faccio, et al. RelB is the NF-{kappa}B subunit downstream of NIK responsible for osteoclast differentiation PNAS, March 11, 2008; 105(10): 3897 - 3902. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Krysov, T. F. Rowley, and A. Al-Shamkhani Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells Mol. Cancer Ther., February 1, 2007; 6(2): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igarashi, Y. Baba, Y. Nagai, E. Jimi, S. Ghosh, and P. W Kincade NF-{kappa}B is dispensable for normal lymphocyte development in bone marrow but required for protection of progenitors from TNF{alpha} Int. Immunol., May 1, 2006; 18(5): 653 - 659. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |